COMMUNIQUÉS West-GlobeNewswire

Solon Eiendom ASA : Primary insider notification
22/09/2017
(Oslo, Norway, 21 September 2017) Per Knut Asphaug Bernhardt, personal assistant to the chairman of the board of Solon Eiendom ASA, (through his wholly owned company Factum AS) has today acquired a forward contract with [...]
Participation de XBiotech à la conférence Global Healthcare de Cantor Fitzgerald
22/09/2017
AUSTIN, Texas, le 22 septembre 2017 (GLOBE NEWSWIRE) - XBiotech Inc. (NASDAQ:XBIT) a annoncé aujourd'hui la participation de sa direction à la conférence Global Healthcare de Cantor Fitzgerald qui se tiendra du 25 au 27 [...]
Orion Pharma scientists led research group wins award for study paper on dexmedetomidine oromucosal gel for noise anxiety in dogs
22/09/2017
ORION CORPORATION PRESS RELEASE 22 SEPTEMBER 2017 at 8.30 EEST Orion Pharma scientists led research group wins award for study paper on dexmedetomidine oromucosal gel for noise anxiety in dogs Orion Pharma scientists [...]
Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries
22/09/2017
CMLPath to Care(TM) collaboration replaces Glivec International Patient Access Program (GIPAP) with a new, independent, patient-centered access model GIPAP was introduced 15 years ago and has provided approximately 75, [...]
Invitation to the extraordinary shareholders' meeting
22/09/2017
September 22, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Bone Therapeutics SA and Asahi Kasei sign exclusive license agreement for PREOB® in Japan
22/09/2017
Regulated information Bone Therapeutics and Asahi Kasei sign exclusive license agreement for PREOB ® in Japan Asahi Kasei obtains exclusive license for the development and commercialisation of PREOB ® in Japan Option to [...]
Bone Therapeutics SA et Asahi Kasei signent un accord de licence exclusive portant sur PREOB® au Japon
22/09/2017
Information réglementée Bone Therapeutics et Asahi Kasei signent un accord de licence exclusive portant sur PREOB ® au Japon Licence exclusive délivrée à Asahi Kasei pour le développement et la commercialisation de [...]
Merus annonce ses résultats financiers du deuxième trimestre 2017 et souligne ses récents progrès
22/09/2017
UTRECHT, Pays-Bas, le 22 septembre 2017 (GLOBE NEWSWIRE). - Merus N.V. (NASDAQ : MRUS), entreprise d'immuno-oncologie de stade clinique qui développe des traitements innovants à base d'anticorps bispécifiques (Biclonics [...]
XBiotech annonce un accord avec le Cedars-Sinai Medical Center pour évaluer MABp1 en association avec Onivyde® et 5-fluorouracile / acide folinique pour le traitement du cancer du pancréas
22/09/2017
AUSTIN, Texas, le 22 septembre 2017 (GLOBE NEWSWIRE). - XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd'hui son accord avec le Cedars-Sinai Medical Center situé à Los Angeles, en Californie, selon lequel XBiotech [...]
Galapagos increases share capital through warrant exercises
21/09/2017
Mechelen, Belgium; 21 September 2017, 22.00 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 28,100 new ordinary [...]
CROSSJECT : Résultats du 1er semestre 2017 et point sur l'activité
21/09/2017
Résultats du 1 er semestre 2017 et point sur l'activité Montée en puissance de l'outil industriel en cours : avec quelques ajustements pour sécuriser la conformité GMP Impacts sur le calendrier prévisionnel : report de [...]
Summit Therapeutics plc : Holding(s) in Company
21/09/2017
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : SUMMIT THERAPEUTICS [...]
Medtronic Announces Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) PRO System in 'Everyday' Clinical Practice
21/09/2017
New Study Designed to Assess Longer-Term Clinical Performance of Next-Generation Evolut PRO Transcatheter Aortic Valve Implantation (TAVI) System DUBLIN - September 21, 2017 - Medtronic plc (NYSE: MDT) today announced a [...]
XBiotech to Present at Cantor Fitzgerald's Global Healthcare Conference
21/09/2017
AUSTIN, Texas, Sept. 21, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that management will be presenting at Cantor Fitzgerald's Global Healthcare Conference taking place September 25-27 at the [...]
ProMIS Neurosciences Independent Director Anthony J. Giovinazzo Recognized with Inaugural Bloom Burton Award for Innovation in Canadian Healthcare
21/09/2017
ProMIS TM Neurosciences, Inc. NEWS RELEASE TSX: PMN TORONTO, ONTARIO and CAMBRIDGE, MA - September 21, 2017 - ProMIS Neurosciences, Inc., a company focused on the discovery and development of precision treatments for [...]
Xbrane Biopharma AB: Xbrane attends Carnegie Nordic HealthCare Day in New York, 5 December
21/09/2017
Press release 2017-09-21 Xbrane is pleased to announce its participation in Carnegie Nordic Healthcare Day in New York in collaboration with the Trout Group, 5 December. The event is for institutional investors and is [...]
Bavarian Nordic Provides Update on its Universal RSV Vaccine
21/09/2017
Preliminary 6 Month Phase 2 Data continue to Demonstrate a Broad and Durable Immune Response against RSV Updated Clinical Plans to Develop and Initiate a Human Challenge Study in 2018 COPENHAGEN, Denmark, September 21, [...]
Kymab and Seattle Children's Research Institute publish impressive results using Kymab's KY1005 in a model of Acute Graft versus Host Disease (aGVHD) in Science Translational Medicine
21/09/2017
Kymab and Seattle Children's Research Institute publish impressive results using Kymab's KY1005 in a model of Acute Graft versus Host Disease (aGVHD) in Science Translational Medicine KY1005 in combination with [...]
Immunicum AB (publ) to Present Preclinical Data on Ilixadencel's Mode of Action at the SITC Meeting in the US
21/09/2017
Press Release 21 September 2017 Immunicum AB (publ) to Present Preclinical Data on Ilixadencel's Mode of Action at the SITC Meeting in the US Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company [...]

Pages